Bank of America Corporation »

Adaptimmune Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.7M 4.7M 0.79
2023-09-30 $3.7M 4.7M 0.78
2023-06-30 $4.3M 4.7M 0.93
2023-03-31 $5.9M 5.4M 1.09
2022-12-31 $6.9M 4.7M 1.46
2022-06-30 $1.7M 991k 1.70
2021-12-31 $2.0M 538k 3.77
2021-06-30 $48k 13k 3.73
2021-03-31 $1.9M 355k 5.31
2020-12-31 $13k 2.3k 5.59
2020-09-30 $14k 1.6k 8.70
2020-06-30 $22k 2.2k 10.05
2020-03-31 $0 2.3k 0.00
2019-12-31 $6.0k 5.2k 1.15
2019-03-31 $1.0k 267 3.75
2018-12-31 $6.4k 1.2k 5.45
2018-06-30 $46k 3.9k 11.70
2018-03-31 $67k 5.9k 11.36
2017-12-31 $86k 13k 6.80
2017-09-30 $6.0k 738 8.13
2016-06-30 $173k 16k 10.75
2016-03-31 $3.0k 353 8.50
2015-06-30 $4.0k 200 20.00